The brain-gut Axis in abdominal pain syndromes

Annual Review of Medicine

Volumn 62, Issue , 2011, Pages 381-396

  Mayer, Emeran A ^a,b   Tillisch, Kirsten ^a,b  

^a Digestive Disease Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

functional dyspepsia; interoception; irritable bowel syndrome

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN RELEASING FACTOR; NERVE GROWTH FACTOR; SUBSTANCE P;

ABDOMINAL PAIN; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BRAIN GUT AXIS; COGNITION; DYSPEPSIA; EMOTION; FUNCTIONAL ABDOMINAL PAIN SYNDROME; HELICOBACTER PYLORI; HOMEOSTASIS; HUMAN; INTERSTITIAL CYSTITIS; INTESTINE DISTENSION; INTESTINE INNERVATION; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MAST CELL; NERVE CELL PLASTICITY; NEUROBIOLOGY; NOCICEPTION; PAINFUL BLADDER SYNDROME; PRIORITY JOURNAL; SPINAL CORD; STRESS; THORAX PAIN; VISCERAL PAIN;

ABDOMINAL PAIN; BRAIN; CHRONIC DISEASE; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HOMEOSTASIS; HUMANS; MALE; MAST CELLS; NEUROIMMUNOMODULATION; SPINAL CORD; SYNDROME;

EID: 79551574749     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-med-012309-103958     Document Type: Article

References (83)

1. Mayer EA, Saper CB, eds 2000. The Biological Basis for Mind Body Interactions. Amsterdam Elsevier
2. Chang L, Drossman DA. 2009. Irritable bowel syndrome and related functional disorders. In Functional Pain Syndromes: Presentation and Pathophysiology, ed. EA Mayer, C Bushnell, pp. 87-120. Seattle, WA: Intl. Assoc. Stud. Pain Press
3. Mimidis K, Tack J. 2008. Pathogenesis of dyspepsia. Dig. Dis. 26:194-202
4. Parkman HP, Camilleri M, Farrugia G, et al. 2010. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol. Motil. 22:113-33
5. Mayer EA. 2000. The neurobiology of stress and gastrointestinal disease. Gut 47:861-69
6. Bielefeldt K, Christianson JA, Davis BM. 2005. Basic and clinical aspects of visceral sensation: transmission in the CNS. Neurogastroenterol. Motil. 17:488-99
7. Mayer EA, Naliboff BD, Craig AD. 2006. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 131:1925-42
8. Berntson GG, Sarter M, Cacioppo JT. 2003. Ascending visceral regulation of cortical affective information processing. Eur. J. Neurosci. 18:2103-9
9. Grundy D, Scratcherd T, Schultz SG, et al. 1989. Sensory afferents from the gastrointestinal tract. In Handbook of Physiology. The Gastrointestinal System, I:593-620. Bethesda, MD: Am. Physiol. Soc
10. Jänig W, Undem BJ, Weinreich D. 2005. Vagal afferents and visceral pain. In Advances in Vagal Afferent Neurobiology, pp. 465-94. Boca Raton, FL: CRC Taylor and Francis Group
11. Porreca F, Ossipov MH, Gebhart GF. 2002. Chronic pain and medullary descending facilitation. Trends Neurosci. 25:319-25
12. Mayer EA, Collins SM. 2002. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 122:2032-48
13. Mayer EA, Naliboff BD, Chang L, et al. 2001. Stress and the gastrointestinal tract: V. Stress and irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G519-G24
14. Longstreth GF, Thompson WG, Chey WD, et al. 2006. Functional bowel disorders. Gastroenterology 130:1480-91
15. Halder SL, Locke GR 3rd, Schleck CD, et al. 2007. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 133:799-807
16. Mayer EA, Bushnell MC. 2009. Functional pain disorders: time for a paradigm shift? In Functional Pain Syndromes: Presentation and Pathophysiology, ed. EA Mayer, MC Bushnell, pp. 531-65. Seattle: IASP Press
17. Spiegel B, Bolus R, Harris LA, et al. 2009. Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment. Pharmacol. Ther. 30:1159-70
18. Christianson JA, Bielefeldt K, Altier C, et al. 2009. Development, plasticity and modulation of visceral afferents. Brain Res. Rev. 60:171-86
19. Vergnolle N. 2008. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol. Motil. 20(Suppl. 1):73-80
20. Moore BA, Stewart TM, Hill C, et al. 2002. TNBS ileitis evokes hyperexcitability and changes in ionic membrane properties of nociceptive DRG neurons. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G1045- 51
21. Spiller R, Garsed K. 2009. Postinfectious irritable bowel syndrome. Gastroenterology 136:1979-88
22. Rhee SH, Pothoulakis C, Mayer EA. 2009. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 6:306-14
23. Collins SM, Bercik P. 2009. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136:2003-14
24. Collins SM, Denou E, Verdu EF, et al. 2009. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig. Liver Dis. 41:850-53
25. Ohman L, Simren M. 2010. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat. Rev. Gastroenterol. Hepatol. 7:163-73
26. Chadwick VS, Chen W, Shu D, et al. 2002. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122:1778-83
27. Dunlop SP, Jenkins D, Neal KR, et al. 2003. Randomized, double-blind, placebo-controlled trial of prednisolone in postinfectious irritable bowel syndrome. Aliment. Pharmacol. Ther. 18:77-84
28. Hanno PM, Wein AJ, Kavoussi LR, et al. 2007. Painful bladder syndrome/interstitial cystitis and related disorders. In Campbell-Walsh Urology. Philadelphia: W.B. Saunders Co
29. Santos J, Guilarte M, Alonso C, et al. 2005. Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand. J. Gastroenterol. 40:129-40
30. Buhner S, Li Q, Vignali S, et al. 2009. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 137:1425-34
31. Barbara G, Wang B, Stanghellini V, et al. 2007. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132:26-37
32. Cenac N, Andrews CN, Holzhausen M, et al. 2007. Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Invest. 117:636-47
33. Theoharides TC. 2004. Panic disorder, interstitial cystitis, and mast cells. J. Clin. Psychopharmacol. 24:361-64
34. Theoharides TC, Cochrane DE. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146:1-12
35. Bradesi S, Tillisch K, Mayer E. 2006. Emerging drugs for irritable bowel syndrome. Expert Opin. Emerg. Drugs 11:293-313
36. Barbara G, Stanghellini V, De Giorgio R, et al. 2004. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126:693-702
37. Bienenstock J, MacQueen G, Sestini P, et al. 1991. Mast cell/nerve interactions in vitro and in vivo. Am. Rev. Respir. Dis. 143:S55-58
38. Bauer O, Razin E. 2000. Mast cell-nerve interactions. News Physiol. Sci. 15:213-18
39. Sant GR, Theoharides TC. 1994. The role of the mast cell in interstitial cystitis. Urol. Clin. North Am. 21:41-53
40. Dunlop SP, Hebden J, Campbell E, et al. 2006. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am. J. Gastroenterol. 101:1288-94
41. Marshall JK, Thabane M, Garg AX, et al. 2004. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment. Pharmacol. Ther. 20:1317-22
42. Piche T, Barbara G, Aubert P, et al. 2009. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58:196-201
43. Soderholm JD, Yang PC, Ceponis P, et al. 2002. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123:1099-108
44. Soderholm JD, Yates DA, Gareau MG, et al. 2002. Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G1257-G63
45. Meddings JB. 1997. Review article: intestinal permeability in Crohn's disease. Aliment. Pharmacol. Ther. 11(Suppl. 3):47-53; discussion 53-56
46. Soderholm JD, Perdue MH. 2001. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G7-G13
47. Vergnolle N, Bunnet NW, Sharkey KA, et al. 2001. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. 7:821-26
48. Mayer EA, Gebhart GF. 1994. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107:271-93
49. Martinez V, Taché Y. 2006. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr. Pharm. Des. 12:4071-88
50. Bradesi S, Schwetz I, Ennes HS, et al. 2005. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G42-G53
51. Mayer EA, Bradesi S, Chang L, et al. 2008. Functional GI disorders: from animal models to drug development. Gut 57:384-404
52. Mayer EA, Aziz Q, Coen S, et al. 2009. Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol. Motil. 21:579-96
53. Tillisch K, Bueller J, Berman S, et al. 2006. Sex-specific alterations in central autonomic function among patients with irritable bowel syndrome. Gastroenterology 130:A445 (Abstr.)
54. Bradesi S. 2010. Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol. Motil. 22:499-511
55. Wilder-Smith CH, Schindler D, Lovblad K, et al. 2004. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 53:1595-601
56. Tillisch K, Labus JS, Mayer EA. 2010. Central network activation in irritable bowel syndrome and healthy controls: a quantitative meta-analysis. Gastroenterology. Epub ahead of print
57. Labus JS, Naliboff BN, Fallon J, et al. 2008. Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage 41:1032-43
58. Phillips ML, Gregory LJ, Cullen S, et al. 2003. The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain 126:669-84
59. Labus J, Bolus R, Chang L, et al. 2004. The visceral sensitivity index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment. Pharmacol. Ther. 20:89-97
60. Mayer EA, Berman S, Suyenobu B, et al. 2005. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain 115:398-409
61. Schweinhardt P, Sauro KM, Bushnell MC. 2008. Fibromyalgia: a disorder of the brain? Neuroscientist 14:415-21
62. Seminowicz DA, Labus JS, Bueller JA, et al. 2010. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 139:48-57
63. Schweinhardt P, Kuchinad A, Pukall CF, et al. 2008. Increased gray matter density in young women with chronic vulvar pain. Pain 140:411-19
64. Saito YA, Zimmerman JM, Harmsen WS, et al. 2008. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol. Motil. 20:790-97
65. Holstege G, Bandler R, Saper CB, et al. 1996. The emotional motor system. In The Emotional Motor System, ed. G Holstege, R Bandler, CB Saper, pp. 3-6. Amsterdam: Elsevier
66. Jaenig W, Habler HJ, Mayer EA, et al. 2000. Specificity in the organization of the autonomic nervous system: a basis for precise neural regulation of homeostatic and protective body functions. See Reference 1, pp. 351-67
67. Kau AL, Hunstad DA, Hultgren SJ. 2005. Interaction of uropathogenic Escherichia coli with host uroep-ithelium. Curr. Opin. Microbiol. 8:54-59
68. Domingue GJ, Ghoniem GM, Bost KL, et al. 1995. Dormant microbes in interstitial cystitis. J. Urol. 153:1321-26
69. Camilleri M, Chang L. 2008. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology 135:1877-91
70. Bradesi S, Tillisch K, Mayer E. 2006. Emerging drugs for irritable bowel syndrome. Exp. Opin. Emerg. Drugs 11:293-313
71. Mayer EA, Tillisch K, Bradesi S. 2006. Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment. Pharmacol. Ther. 24:919-33
72. Mayer EA, Bradesi S. 2003. Alosetron and irritable bowel syndrome. Exp. Opin. Pharmacother. 4:2089-98
73. Martinez V, Taché Y. 2006. CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr. Pharmaceut. Design 12:4071-88
74. Sweetser S, Camilleri M, Linker Nord SJ, et al. 2009. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am. J. Physiol. Gastrointest. Liver Physiol. 296:G1299-306
75. Camilleri M. 2010. New receptor targets for medical therapy in irritable bowel syndrome. Aliment. Pharmacol. Ther. 31:35-46
76. Camilleri M, Kerstens R, Rykx A, et al. 2008. A placebo-controlled trial of prucalopride for severe chronic constipation. N. Engl. J. Med. 358:2344-54
77. Camilleri M. 2001. Tegaserod. Aliment. Pharmacol. Ther. 15:277-89
78. Pimentel M. 2009. Review of rifaximin as treatment for SIBO and IBS. Exp. Opin. Investig. Drugs 18:349-58
79. Moayyedi P, Ford AC, Talley NJ, et al. 2010. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59:325-32
80. Lackner JM, Mesmer C, Morley S, et al. 2004. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J. Consult. Clin. Psychol. 72:1100-13
81. Lackner JM, Lou Coad M, Mertz HR, et al. 2006. Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety. Behav. Res. Ther. 44:621-38
82. Craig AD. 2002. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. Neurosci. 3:655-66
83. Mayer EA. 2009. Pathophysiology of persistent abdominal and pelvic pain. In Pain 2010-An Updated Review: Refresher Course Syllabus, ed. JS Mogil. Seattle: Intl. Assoc. Stud. Pain